Delivery Order SPE2DB20D2104-SPE2DB23FV31L
Award Date
9/13/23
Potential Completion Date
9/14/23
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a ceiling value of $30,299.21 and is a Firm Fixed Price agreement. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,497.78 Firm Fixed Price Delivery Order is for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has an ultimate completion date of December 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $13,762.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, to provide NASCOBAL 500 MCG NASAL SPRAYS to support federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,367.30 firm fixed-price delivery order is for the supply of NASCOBAL 500 MCG nasal sprays, with a period of performance through January 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,279.49 firm-fixed-price delivery order is for the supply of NASCOBAL 500 MCG NASAL SPRAYS, with a completion date of April 3, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the procurement of NASCOBAL 500 MCG NASAL SPRAYS. The contract, with a ceiling value of $13,814.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a firm fixed price pricing type, and an ultimate completion date of December 15, 2023. It is not designated with a set-aside requirement, indicating open competition....
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS57W, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,719.53 firm fixed-price delivery order is for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has an ultimate completion date of March 13, 2023 and was awarded on March 10, 2023. It is not designated as a set-aside. Amerisourcebergen Drug Corp, a subsidiary of...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of Nascobal 500 mcg nasal sprays. The $5,039.89 firm fixed-price delivery order has a completion date of May 23, 2022. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
The Defense Logistics Agency awarded a $8,707 firm fixed price delivery order to Amerisourcebergen Drug Corporation for NASCOBAL 500 MCG nasal sprays. Under this order, Amerisourcebergen will deliver 4561504619 units of the specified nasal spray product to a location in Conshohocken, Pennsylvania by July 17, 2023. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for worldwide logistics support. This delivery order was issued against...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,325.92 contract is for the supply of QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product. The award has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...